Radiotherapy in Association With Cetuximab in Patients Treated for an Epidermoid Cancer

• Status: Unknown status
• Trial end date: 2014-12-01
• Target enrollment: 0
• Participant gender: All

Summary

This study evaluates the skin toxicities in patients with epidermoid cancer, treated by Radiotherapy in association with Cetuximab.

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Centre Oscar Lambret
• Treatments: Cetuximab

Criteria

Inclusion Criteria:

• Age > 18 years

• Epidermoid head and neck carcinoma locally advanced

• Indication of Cetuximab and radiotherapy

• Karnofsky >= 60

• Patients participating to another compatible study could be included after consultation with the study director Patients could be beforehand treated for an other ORL cancer

The radiotherapy will be delivered for curative aim (minimal dose 66 Gy)

Exclusion Criteria:

• other histology

• Metastatic disease

• Recurrent patients